Ajay Royan serves as Executive at Adagio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ajay Royan has executed 5 insider transactions totaling $38.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 6, 2024 involved exercising options for 5,160,301 shares valued at $0.
Ajay Royan currently holds 5,160,301 shares of Adagio Therapeutics, Inc. (ADGI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ajay Royan has been a net buyer of ADGI stock. They have purchased $38.9M and sold $0 worth of shares.
Ajay Royan's most recent insider trade was on Feb 6, 2024, when they sold 5,160,301 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 6, 2024 | GUTS | $5.0M | Purchase | 333,333 | $15.00 | Discretionary |
| Aug 10, 2021 | ADGI | $33.9M | Purchase | 1,997,000 | $17.00 | Discretionary |
| Aug 10, 2021 | ADGI | $0 | Conversion | 9,244,580 | $N/A | Discretionary |